Cargando…

A post-authorisation survey to analyse the perioperative teicoplanin plasma concentrations in adult patients with chronic bone sepsis, who received loading doses of 12 mg/kg 12-hourly for 48 hours followed by 12 mg/kg once daily

Detalles Bibliográficos
Autores principales: Brink, AJ, Richards, G, Lautenbach, C, Rapeport, N, Schillack, V, Roberts, J, Lipman, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363487/
http://dx.doi.org/10.1186/cc10676
_version_ 1782234362139377664
author Brink, AJ
Richards, G
Lautenbach, C
Rapeport, N
Schillack, V
Roberts, J
Lipman, J
author_facet Brink, AJ
Richards, G
Lautenbach, C
Rapeport, N
Schillack, V
Roberts, J
Lipman, J
author_sort Brink, AJ
collection PubMed
description
format Online
Article
Text
id pubmed-3363487
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33634872012-05-31 A post-authorisation survey to analyse the perioperative teicoplanin plasma concentrations in adult patients with chronic bone sepsis, who received loading doses of 12 mg/kg 12-hourly for 48 hours followed by 12 mg/kg once daily Brink, AJ Richards, G Lautenbach, C Rapeport, N Schillack, V Roberts, J Lipman, J Crit Care Poster Presentation BioMed Central 2012 2012-03-20 /pmc/articles/PMC3363487/ http://dx.doi.org/10.1186/cc10676 Text en Copyright ©2012 Brink et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Brink, AJ
Richards, G
Lautenbach, C
Rapeport, N
Schillack, V
Roberts, J
Lipman, J
A post-authorisation survey to analyse the perioperative teicoplanin plasma concentrations in adult patients with chronic bone sepsis, who received loading doses of 12 mg/kg 12-hourly for 48 hours followed by 12 mg/kg once daily
title A post-authorisation survey to analyse the perioperative teicoplanin plasma concentrations in adult patients with chronic bone sepsis, who received loading doses of 12 mg/kg 12-hourly for 48 hours followed by 12 mg/kg once daily
title_full A post-authorisation survey to analyse the perioperative teicoplanin plasma concentrations in adult patients with chronic bone sepsis, who received loading doses of 12 mg/kg 12-hourly for 48 hours followed by 12 mg/kg once daily
title_fullStr A post-authorisation survey to analyse the perioperative teicoplanin plasma concentrations in adult patients with chronic bone sepsis, who received loading doses of 12 mg/kg 12-hourly for 48 hours followed by 12 mg/kg once daily
title_full_unstemmed A post-authorisation survey to analyse the perioperative teicoplanin plasma concentrations in adult patients with chronic bone sepsis, who received loading doses of 12 mg/kg 12-hourly for 48 hours followed by 12 mg/kg once daily
title_short A post-authorisation survey to analyse the perioperative teicoplanin plasma concentrations in adult patients with chronic bone sepsis, who received loading doses of 12 mg/kg 12-hourly for 48 hours followed by 12 mg/kg once daily
title_sort post-authorisation survey to analyse the perioperative teicoplanin plasma concentrations in adult patients with chronic bone sepsis, who received loading doses of 12 mg/kg 12-hourly for 48 hours followed by 12 mg/kg once daily
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363487/
http://dx.doi.org/10.1186/cc10676
work_keys_str_mv AT brinkaj apostauthorisationsurveytoanalysetheperioperativeteicoplaninplasmaconcentrationsinadultpatientswithchronicbonesepsiswhoreceivedloadingdosesof12mgkg12hourlyfor48hoursfollowedby12mgkgoncedaily
AT richardsg apostauthorisationsurveytoanalysetheperioperativeteicoplaninplasmaconcentrationsinadultpatientswithchronicbonesepsiswhoreceivedloadingdosesof12mgkg12hourlyfor48hoursfollowedby12mgkgoncedaily
AT lautenbachc apostauthorisationsurveytoanalysetheperioperativeteicoplaninplasmaconcentrationsinadultpatientswithchronicbonesepsiswhoreceivedloadingdosesof12mgkg12hourlyfor48hoursfollowedby12mgkgoncedaily
AT rapeportn apostauthorisationsurveytoanalysetheperioperativeteicoplaninplasmaconcentrationsinadultpatientswithchronicbonesepsiswhoreceivedloadingdosesof12mgkg12hourlyfor48hoursfollowedby12mgkgoncedaily
AT schillackv apostauthorisationsurveytoanalysetheperioperativeteicoplaninplasmaconcentrationsinadultpatientswithchronicbonesepsiswhoreceivedloadingdosesof12mgkg12hourlyfor48hoursfollowedby12mgkgoncedaily
AT robertsj apostauthorisationsurveytoanalysetheperioperativeteicoplaninplasmaconcentrationsinadultpatientswithchronicbonesepsiswhoreceivedloadingdosesof12mgkg12hourlyfor48hoursfollowedby12mgkgoncedaily
AT lipmanj apostauthorisationsurveytoanalysetheperioperativeteicoplaninplasmaconcentrationsinadultpatientswithchronicbonesepsiswhoreceivedloadingdosesof12mgkg12hourlyfor48hoursfollowedby12mgkgoncedaily
AT brinkaj postauthorisationsurveytoanalysetheperioperativeteicoplaninplasmaconcentrationsinadultpatientswithchronicbonesepsiswhoreceivedloadingdosesof12mgkg12hourlyfor48hoursfollowedby12mgkgoncedaily
AT richardsg postauthorisationsurveytoanalysetheperioperativeteicoplaninplasmaconcentrationsinadultpatientswithchronicbonesepsiswhoreceivedloadingdosesof12mgkg12hourlyfor48hoursfollowedby12mgkgoncedaily
AT lautenbachc postauthorisationsurveytoanalysetheperioperativeteicoplaninplasmaconcentrationsinadultpatientswithchronicbonesepsiswhoreceivedloadingdosesof12mgkg12hourlyfor48hoursfollowedby12mgkgoncedaily
AT rapeportn postauthorisationsurveytoanalysetheperioperativeteicoplaninplasmaconcentrationsinadultpatientswithchronicbonesepsiswhoreceivedloadingdosesof12mgkg12hourlyfor48hoursfollowedby12mgkgoncedaily
AT schillackv postauthorisationsurveytoanalysetheperioperativeteicoplaninplasmaconcentrationsinadultpatientswithchronicbonesepsiswhoreceivedloadingdosesof12mgkg12hourlyfor48hoursfollowedby12mgkgoncedaily
AT robertsj postauthorisationsurveytoanalysetheperioperativeteicoplaninplasmaconcentrationsinadultpatientswithchronicbonesepsiswhoreceivedloadingdosesof12mgkg12hourlyfor48hoursfollowedby12mgkgoncedaily
AT lipmanj postauthorisationsurveytoanalysetheperioperativeteicoplaninplasmaconcentrationsinadultpatientswithchronicbonesepsiswhoreceivedloadingdosesof12mgkg12hourlyfor48hoursfollowedby12mgkgoncedaily